Sự phát triển của liệu pháp xạ trị định vị (SBRT) cho ung thư phổi không tế bào nhỏ giai đoạn sớm không thể phẫu thuật: Một hiện tượng toàn cầu

Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90 Zhou W, Christiani DC (2011) East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians. Chin J Cancer 30:287–292 Hansen H (2009) Histopathology. In: Hansen H (ed) Lung cancer therapy annual, 6th edn. Informa Health Care, New York, pp 45–56 Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300 Juettner-Smolle FMLJ, Matzi V, Neubock N (2010) Resection in stage I/II non-small cell lung cancer. In: Controversies in the treatment of lung cancer. J H (ed) Karger, Basel, Switzerland, pp 71–77 Little AG, Rusch VW, Bonner JA et al (2005) Patterns of surgical care of lung cancer patients. Ann Thorac Surg 80:2051–2056 Sweden TNLCRI: the national lung cancer register in Sweden. http://www.roc.se McGarry RC, Song G, des Rosiers P et al (2002) Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest 121:1155–1158 Jensik RJ, Faber LP, Milloy FJ et al (1973) Segmental resection for lung cancer. A fifteen-year experience. J Thorac Cardiovasc Surg 66:563–572 Sibley GS (1998) Radiotherapy for patients with medically inoperable Stage I nonsmall cell lung carcinoma: smaller volumes and higher doses—a review. Cancer 82:433–438 Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60:615–622 Dahele M, Senan S (2011) The role of stereotactic ablative radiotherapy for early-stage and oligometastatic non-small cell lung cancer: evidence of changing paradigms. Cancer Res Treat 43:75–82 Perez CA, Pajak TF, Rubin P et al (1987) Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 59:1874–1881 Qiao X, Tullgren O, Lax I et al (2003) The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41:1–11 Allen MS, Darling GE, Pechet TT et al (2006) Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81:1013–1019 Martel MK, Ten Haken RK, Hazuka MB, et al. (1999) Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24:31–37. Int J Radiat Oncol Biol Phys. 2006; 64:120–126 Chen M, Hayman JA, Ten Haken RK et al (2006) Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3 N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys 64:120–126 Saunders M, Dische S, Barrett A et al (1997) Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet 350:161–165 Leksell L (1983) Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry 46:797–803 Song DY, Kavanagh BD, Benedict SH, Schefter T (2004) Stereotactic bodyradiation therapy. Rationale, techniques, applications, and optimization. Oncology 18:1419–1430 Lax I, Blomgren H, Naslund I, Svanstrom R (1994) Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33:677–683 Blomgren H, Lax I, Naslund I, Svanstrom R (1995) Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34:861–870 Uematsu M, Shioda A, Tahara K et al (1998) Focal, high dose, and fractionated modified stereotactic radiationtherapy for lung carcinoma patients: a preliminary experience. Cancer 82:1062–1070 McGarry RC, Papiez L, Williams M et al (2005) Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63:1010–1015 Fakiris AJ, McGarry RC, Yiannoutsos CT et al (2009) Stereotactic body radiation therapy for early-stage non small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75:677–682 Timmerman R, McGarry R, Yiannoutsos C et al (2006) Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833–4839 Nagata Y, Hiraoka M, Mizowaki T et al (2009) Survey of stereotactic body radiation therapy in Japan by the 3-D External Beam Radiotherapy Group. Int J Radiat Oncol Biol Phys 75:343–347 Onishi H, Shirato H, Nagata Y et al (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi institutional study. J Thorac Oncol 2:S94–S100 Fowler JF, Tome WA, Fenwick JD, Mehta MP (2004) A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 60:1241–1256 Nagata Y, Takayama K, Matsuo Y et al (2005) Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63:1427–1431 Uematsu M, Shioda A, Suda A et al (2001) Computed tomography guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51:666–670 Baumann P, Nyman J, Lax I et al (2006) Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 45:787–795 Guckenberger M, Wulf J, Mueller G et al (2009) Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys 74:47–54 Lagerwaard FJ, Haasbeek CJ, Smit EF et al (2008) Outcomes of risk adapted fractionated stereotactic radiotherapy for stage I non small-cell lung cancer. Int J Radiat Oncol Biol Phys 70:685–692 Wulf J, Baier K, Mueller G, Flentje MP (2005) Dose–response in stereotactic irradiation of lung tumors. Radiother Oncol 77:83–87 Timmerman R, Papiez L, McGarry R et al (2003) Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124:1946–1955 Stephans KL, Djemil T, Reddy CA et al (2009) A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience. J Thorac Oncol 4:976–982 Haasbeek CJ, Lagerwaard FJ, de Jaeger K et al (2009) Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising post pneumonectomy. Cancer 115:587–594 Haasbeek CJ, Lagerwaard FJ, Antonisse ME et al (2010) Stage I non small cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy. Cancer 116:406–414 Timmerman R, Paulus R, Galvin J et al (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303:1070–1076 Baumann P, Nyman J, Hoyer M et al (2009) Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27:3290–3296 Ricardi U, Filippi AR, Guarneri A et al (2010) Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 68:72–77 Nyman J, Johansson KA, Hultén U (2006) Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—mature results for medically inoperable patients. Lung Cancer 51:97–103 Bradley J (2007) Radiographic response and clinical toxicity following SBRT for stage I lung cancer. J Thorac Oncol 2:S118–S124 Takeda A, Kunieda E, Takeda T et al (2008) Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 70:1057–1065 Henderson MA, Hoopes DJ, Fletcher JW et al (2010) A pilot trial of serial 18 F-fluorodeoxyglucose positron emission tomography inpatients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76:789–795 Chang JY, Roth JA (2007) Stereotactic body radiation therapy for stage I non-small cell lung cancer. Thorac Surg Clin 17:251–259 May BJ, Levsky JM, Godelman A et al (2011) Should CT play a greater role in preventing the resection of granulomas in the era of PET? AJR Am J Roentgenol 196:795–800 Henderson M, McGarry R, Yiannoutsos C et al (2008) Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 72:404–409 Stephans KL, Djemil T, Reddy CA et al (2009) Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol 4:838–844 Dunlap NE, Cai J, Biedermann GB et al (2010) Chest wall volume receiving >30 Gy predicts risk of severe pain and/or stricture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76:796–801 Pettersson N, Nyman J, Johansson KA (2009) Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis. Radiother Oncol 91:360–368 Timmerman R, Galvin J, Michalski J et al (2006) Accreditation and quality assurance for Radiation Therapy Oncology Group: multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol 45:779–786 De Ruysscher D, Faivre-Finn C, Nestle U et al. European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol 28:5301–5310 Nagata Y, Wulf J, Lax I et al (2011) Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 79:660–669